Treatment of amyotrophic lateral sclerosis

Details for Australian Patent Application No. 2005249234 (hide)

Owner VIB vzw Life Sciences Research Partners vzw

Inventors Carmeliet, Peter

Agent Davies Collison Cave

Pub. Number AU-B-2005249234

PCT Pub. Number WO2005/117946

Priority 04102334.2 27.05.04 EP

Filing date 27 May 2005

Wipo publication date 15 December 2005

Acceptance publication date 5 August 2010

International Classifications

A61K 9/00 (2006.01) Medicinal preparations characterised by special physical form

A61K 38/18 (2006.01) Medicinal preparations containing peptides - Growth factors

A61K 38/19 (2006.01) Medicinal preparations containing peptides - Cytokines

Event Publications

4 January 2007 PCT application entered the National Phase

  PCT publication WO2005/117946 Priority application(s): WO2005/117946

11 June 2009 Alteration of Name

  The name of the applicant has been altered to VIB vzw; Life Sciences Research Partners vzw

5 August 2010 Application Accepted

  Published as AU-B-2005249234

2 December 2010 Standard Patent Sealed

6 January 2011 Licence Registered

  VIB vzw; Life Sciences Research Partners vzw ( NeuroNova AB ) Discharge of a Mortgage

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005249236-Method to reduce hepatotoxicity of Fasmediated apoptosis-inducing agents

2005249233-Stabilized interferon liquid formulations